RecallDepth
Class II Terminated

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

Company
Remedyrepack Inc.
Recall Initiated
February 7, 2017
Posted
March 1, 2017
Recall Number
D-0482-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
630 pills (21 bottles x 30 pills per HDPE bottle)
Firm Location
Indiana, PA, United States

Reason for Recall

Failed Dissolution Specifications

Distribution

Product was distributed to a sold customer in FL.

Lot / Code Info

Lot # B0129373-021916; Exp. 10/17 00591-0900-30 Original NDC 52125-0764-02 RemedyRepack NDC

More recalls by Remedyrepack Inc.

View all recalls by this company →

Other recent Class II Drug recalls